- Report
- February 2025
- 70 Pages
Australia
From €670EUR$735USD£564GBP
€957EUR$1,050USD£806GBP
- Report
- October 2024
- 70 Pages
Japan
From €637EUR$699USD£537GBP
€910EUR$999USD£767GBP
- Report
- March 2024
- 75 Pages
China
From €670EUR$735USD£564GBP
€957EUR$1,050USD£806GBP
- Report
- August 2022
- 70 Pages
United Kingdom
From €701EUR$769USD£591GBP
€1001EUR$1,099USD£844GBP
- Report
- January 2022
- 65 Pages
India
From €631EUR$693USD£532GBP
€902EUR$990USD£760GBP
- Report
- June 2021
- 140 Pages
United States
From €1594EUR$1,750USD£1,344GBP
€2278EUR$2,500USD£1,919GBP
- Report
- November 2023
- 190 Pages
Global
From €4100EUR$4,500USD£3,455GBP
- Report
- November 2023
- 180 Pages
Global
From €4100EUR$4,500USD£3,455GBP
- Report
- January 2025
- 90 Pages
Australia
From €3189EUR$3,500USD£2,687GBP
- Report
- December 2024
- 85 Pages
Spain
From €3189EUR$3,500USD£2,687GBP
- Report
- May 2024
- 90 Pages
United States
From €3189EUR$3,500USD£2,687GBP
- Report
- October 2023
- 181 Pages
Global
From €4100EUR$4,500USD£3,455GBP
- Report
- August 2023
- 73 Pages
Egypt
From €3189EUR$3,500USD£2,687GBP
- Report
- July 2023
- 75 Pages
United States
From €3189EUR$3,500USD£2,687GBP
- Report
- April 2023
- 120 Pages
Global
From €4327EUR$4,750USD£3,647GBP
- Report
- July 2023
- 145 Pages
Global
From €2870EUR$3,150USD£2,418GBP
- Report
- September 2022
- 150 Pages
Middle East, Africa
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2022
- 142 Pages
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2022
- 152 Pages
North America
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2022
- 171 Pages
Europe
From €3143EUR$3,450USD£2,649GBP

Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling.
NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more